Read about breakthrough science, the everyday people who make it happen, and the patients we serve.
Mike Varney keeps Genentech’s research powerhouse focused on uncharted scientific territory.
Our new Global Head of Oncology, Dietmar Berger, reflects on the current state of cancer research and what’s to come, especially at upcoming medical congresses
Just 11 hours after a medicine for metastatic breast cancer was FDA-approved, it was on the way to a patient who needed it.
Tell us what you think about our company, products, or website.
The most exciting phrase to hear in science, the one that heralds new discoveries, is not "Eureka!" but "That’s funny…"